secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2021-09-27T23:59:59+00:00
Accession:  0001607062-21-000355
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Regen Biopharma receives USPTO Notice of Allowance for NR2F6 activity modulators patent
--------------------------------------------------------------------------------

- Notice of Allowance issued Sept 23, 2021 for patent on small molecule agonists/antagonists of NR2F6.
- Invention relates to compounds that alter NR2F6 activity, a nuclear receptor involved in immune regulation.
- Allowed patent strengthens Regen's IP position for its small molecule immunomodulator program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000160706221000355/0001607062-21-000355-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000160706221000355/rgbp092721form8k.htm
  HTML page:      https://secwatch.observer/filing/0001607062-21-000355

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer